Genelux (GNLX) Return on Sales (2022 - 2024)
Genelux (GNLX) posted quarterly Return on Sales of 40.71% for Q4 2024, down 3255.0% year-over-year from 1.29% in Q1 2024, and down 9.01% quarter-over-quarter from 37.35% in Q3 2024.
Genelux (GNLX) Return on Sales (2022 - 2024) Analysis & Trends
Genelux's Return on Sales history runs 3 years deep, the most recent figure standing at 40.71% for Q4 2024.
- In Q4 2024, Return on Sales fell 3255.0% year-over-year to 40.71%; the TTM figure through Dec 2024 stood at 40.71% (down 3255.0% YoY), while the FY2025 annual figure was 138.78%, down 2414.0% from the prior year.
- Return on Sales for Q4 2024 stood at 40.71%, down from 37.35% in the prior quarter.
- The five-year high for Return on Sales was 0.13% in Q3 2023, with the low at 40.71% in Q4 2024.
- The 3-year median for Return on Sales is 5.93% (2023), against an average of 13.76%.
- The sharpest annual moves came in 2023 and 2024: Return on Sales climbed 12 bps in 2023, then plunged 3747 bps in 2024.
- Genelux's Return on Sales stood at 0.0% in 2022, then tumbled by 253181 bps to 8.17% in 2023, then tumbled by 398 bps to 40.71% in 2024.
- Business Quant data shows GNLX's Return on Sales at 40.71% in Q4 2024, 37.35% in Q3 2024, and 35.42% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Genelux | 119.87 Mn | 119.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -40.71% |
| Sep 30, 2024 | -37.35% |
| Jun 30, 2024 | -35.42% |
| Mar 31, 2024 | -11.87% |
| Dec 31, 2023 | -8.17% |
| Sep 30, 2023 | 0.13% |
| Jun 30, 2023 | -3.69% |
| Mar 31, 2023 | -0.56% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |